Does α-Synuclein Have A Dual and Opposing Effect in Preclinical versus Clinical Parkinson’s Disease?

Por Markopoulou, Katerina, Biernacka, Joanna M., Armasu, Sebastian M., Anderson, Kari J., Ahlskog, J. Eric, Chase, Bruce A., Chung, Sun Ju, Cunningham, Julie M., Farrer, Matthew, Frigerio, Roberta, Maraganore, Demetrius M.
Publicado no Parkinsonism Relat Disord (2014)

Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olf...

Por Markopoulou, Katerina, Chase, Bruce A., Robowski, Piotr, Strongosky, Audrey, Narożańska, Ewa, Sitek, Emilia J., Berdynski, Mariusz, Barcikowska, Maria, Baker, Matt C., Rademakers, Rosa, Sławek, Jarosław, Klein, Christine, Hückelheim, Katja, Kasten, Meike, Wszolek, Zbigniew K.
Publicado no PLoS One (2016)

A Swedish family with de novo α-synuclein A53T mutation: Evidence for early cortical dysfunction

Por Puschmann, Andreas, Ross, Owen A., Vilariño-Güell, Carles, Lincoln, Sarah J., Kachergus, Jennifer M., Cobb, Stephanie A., Lindquist, Suzanne G., Nielsen, Jørgen E., Wszolek, Zbigniew K., Farrer, Matthew, Widner, Håkan, van Westen, Danielle, Hägerström, Douglas, Markopoulou, Katerina, Chase, Bruce A., Nilsson, Karin, Reimer, Jan, Nilsson, Christer
Publicado em 2009